(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

AKNEDERM

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

AKNEDERM

ST13

US500000079368504

Class

3, 5

Filing

79368504

Registration

7464549

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

33

Latest update

02/15/2025

Trademark type

Combined

Nice classes

3, 5

Filing date

03/23/2023

Registration date

08/06/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/06/2024

Last transaction

02/15/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

3

Owner type

16

Owner location

Hennef, DE

Examiner

HUDSON, TAMARA

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of the word "AKNEDERM" in blue font beneath the stylized blue outline of a mountain range.

Holders and representatives

Holders

gepepharm GmbH

Representatives

Deborah L. Shapiro Moses & Singer LLP

Technical classification

Nice Classes

Class 3Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 3

Cosmeticsin particular cosmetic ointments and creams; non-medicated cosmetics and toiletry preparations; non-medicated cleansing preparations for the face and body; body oils for toilet purposes; face oils for toilet purposes; skin care preparations in the nature of balmsother than for medical purposes

Class 5

Pharmaceutical preparations and chemical substances for medical or pharmaceutical use for the treatment of acne; pharmaceutical preparations and chemical substances for medical or pharmaceutical use for the treatment of rosacea; pharmaceutical preparations and chemical substances for medical or pharmaceutical use for the treatment of skin disorders; plastersmaterials for wound dressings for medical or pharmaceutical purposes; antiseptic preparations for health care; dietetic preparations adapted for medical use; food supplementsnot for medical purposeswith a base of vitaminsmineralstrace elementsamino acidsvitamin preparationsin the form of granulespowdersemulsionsdrageescapsulesjuicessweetsdrops

Publications

History of USPTO decisions and trademark events.

33 publications found

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

02/15/2025

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

02/08/2025

FICS

FINAL DISPOSITION NOTICE SENT TO IB

01/30/2025

FIMP

FINAL DISPOSITION PROCESSED

01/30/2025

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

01/22/2025

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

01/22/2025

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

11/06/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

08/06/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

08/06/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/21/2024

PUBO

PUBLISHED FOR OPPOSITION

05/21/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/01/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/16/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/10/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/10/2024

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

04/10/2024

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

04/03/2024

GNFR

FINAL REFUSAL E-MAILED

04/03/2024

CNFR

FINAL REFUSAL WRITTEN

04/03/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/22/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/22/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/22/2024

RFNT

REFUSAL PROCESSED BY IB

01/02/2024

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

12/11/2023

RFRR

REFUSAL PROCESSED BY MPU

12/11/2023

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

12/08/2023

CNRT

NON-FINAL ACTION WRITTEN

12/07/2023

DOCK

ASSIGNED TO EXAMINER

12/07/2023

CORR

CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED

09/12/2023

CRCV

CORRECTION TRANSACTION RECEIVED FROM IB

08/27/2023

MAFR

APPLICATION FILING RECEIPT MAILED

05/02/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/28/2023

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

04/27/2023

Continuous trademark protection

Get notified about every new filing that threatens AKNEDERM or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.